Paradigm Biocapital Advisors LP - 13 Nov 2025 SCHEDULE 13G Report for Lexeo Therapeutics, Inc. Common Stock, $0.0001 par value per share (LXEO)

Filing Manager
Paradigm Biocapital Advisors LP
Reporting Manager
Paradigm BioCapital Advisors LP
Security
Lexeo Therapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol
LXEO
Shares outstanding
73,439,980 shares
Disclosed Ownership
3,671,999 shares
Ownership
5%
Form type
SCHEDULE 13G
Filing time
20 Nov 2025, 16:30:17 UTC
Date of event
13 Nov 2025
Next filing
17 Feb 2026
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Paradigm BioCapital Advisors LP 5% 3,671,999 3,671,999 0 /s/ David K. Kim David K. Kim / Authorized Signatory
Paradigm BioCapital Advisors GP LLC 5% 3,671,999 3,671,999 0 /s/ David K. Kim David K. Kim / Authorized Signatory
Senai Asefaw, M.D. 5% 3,671,999 3,671,999 0 /s/ Senai Asefaw, M.D. N/A
Paradigm BioCapital International Fund Ltd. 4.4% 3,244,093 3,244,093 0 /s/ David K. Kim David K. Kim / Authorized Signatory